National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 10602 [E9-5134]
Download as PDF
<![CDATA[
10602
Federal Register / Vol. 74, No. 46 / Wednesday, March 11, 2009 / Notices
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants,
National Institutes of Health, HHS)
Dated: March 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–4990 Filed 3–10–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Division of Intramural Research Board
of Scientific Counselors, NIAID. The
meeting will be closed to the public as
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
rwilkins on PROD1PC63 with NOTICES
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel. Program
Project Review.
Date: April 2, 2009.
Time: 1 p.m to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Eric H. Brown, BS, AB,
MS, Scientific Review Administrator, Office
of Review, National Center for Research
Resources, National Institutes of Health, 6701
Democracy Blvd, Room 1068, MSC 4874,
Bethesda, MD 20892–4874. (301) 435–0815.
browneri@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: June 1–3, 2009.
Time: June 1, 2009, 8 a.m. to 6:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Time: June 2, 2009, 7:30 a.m. to 7:05 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Time: June 3, 2009, 7:30 a.m. to 12:45 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, 50 Center Drive, Conference
Rooms 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD,
Director, Division of Intramural Research,
National Institute of Allergy and Infectious
Diseases, NIH, Building 31, Room 4A30,
Bethesda, MD 20892, 301–496–3006,
kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–5121 Filed 3–10–09; 8:45 am]
Dated: March 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–5134 Filed 3–10–09; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Nov<24>2008
17:01 Mar 10, 2009
Jkt 217001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Program on Drug Resistance.
Date: March 26, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Eric Lorenzo, PhD.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2640,
lorenzoe@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–5137 Filed 3–10–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
AGENCY: Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 74, Number 46 (Wednesday, March 11, 2009)]
[Notices]
[Page 10602]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-5134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Division of Intramural Research Board of Scientific Counselors,
NIAID. The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Allergy and Infectious Diseases, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Division of Intramural Research Board of
Scientific Counselors, NIAID.
Date: June 1-3, 2009.
Time: June 1, 2009, 8 a.m. to 6:15 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Time: June 2, 2009, 7:30 a.m. to 7:05 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Time: June 3, 2009, 7:30 a.m. to 12:45 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, 50 Center
Drive, Conference Rooms 1227/1233, Bethesda, MD 20892.
Contact Person: Kathryn C. Zoon, PhD, Director, Division of
Intramural Research, National Institute of Allergy and Infectious
Diseases, NIH, Building 31, Room 4A30, Bethesda, MD 20892, 301-496-
3006, kzoon@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 4, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-5134 Filed 3-10-09; 8:45 am]
BILLING CODE 4140-01-P
